RE: Drying Paint16 Aug 2023 12:32
Tend to agree. But true value will come in the end. The only thing that bugs me slightly is that the growth rate isn’t great. At this level (current revenues) they should be targeting between 35-50% growth levels year on year if the market is that scalable. They really need to start pumping up the distribution agreements to drive the company forward and trigger the expansion plans asap. I believe 2023 results and the next year is crucial for a turn in sentiment for Tissue Regenix.
For some reason, the company doesn’t seem to appeal to investors. The daily volumes are terribly poor, and this is something the company and nominated brokers need to review and sort out.
It’s amazing how many healthcare companies are valued over 500 million on alternative markets and have been losing tens of millions year on year, and our company is becoming profitable and is valued at a poxy 37 million at the current share price.